154 related articles for article (PubMed ID: 36119530)
1. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer.
Liu C; Qin H; Liu H; Wei T; Wu Z; Shang M; Liu H; Wang A; Liu J; Shang D; Yin P
Front Oncol; 2022; 12():991051. PubMed ID: 36119530
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
Luo X; Liu J; Wang H; Lu H
Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
4. Development of a lipid metabolism-related gene model to predict prognosis in patients with pancreatic cancer.
Xu H; Sun J; Zhou L; Du QC; Zhu HY; Chen Y; Wang XY
World J Clin Cases; 2021 Dec; 9(35):10884-10898. PubMed ID: 35047599
[TBL] [Abstract][Full Text] [Related]
5. Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer.
Li Z; Ma Z; Zhou Q; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Wu Z; Zhao J; Huang S; Zhang C; Hou B
Heliyon; 2022 Nov; 8(11):e11321. PubMed ID: 36406681
[TBL] [Abstract][Full Text] [Related]
6. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
7. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.
Mehta KY; Wu HJ; Menon SS; Fallah Y; Zhong X; Rizk N; Unger K; Mapstone M; Fiandaca MS; Federoff HJ; Cheema AK
Oncotarget; 2017 Sep; 8(40):68899-68915. PubMed ID: 28978166
[TBL] [Abstract][Full Text] [Related]
9. Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis.
Qiu X; Hou QH; Shi QY; Jiang HX; Qin SY
Front Genet; 2020; 11():595361. PubMed ID: 33363572
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
11. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
14. Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer.
Jiang W; Qiao L; Zuo D; Qin D; Xiao J; An H; Wang Y; Zhang X; Jin Y; Ren L
Ann Transl Med; 2021 Feb; 9(4):358. PubMed ID: 33708985
[TBL] [Abstract][Full Text] [Related]
15. A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.
Zhou X; Huang Z; Xu L; Zhu M; Zhang L; Zhang H; Wang X; Li H; Zhu W; Shu Y; Liu P
Oncotarget; 2016 Oct; 7(43):69616-69624. PubMed ID: 27626307
[TBL] [Abstract][Full Text] [Related]
16. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
17. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
18. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
